KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) EBITDA Margin (2016 - 2025)

Repligen (RGEN) has disclosed EBITDA Margin for 16 consecutive years, with 7.51% as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 3841.0% to 7.51% in Q4 2025 year-over-year; TTM through Dec 2025 was 13.4%, a 2012.0% increase, with the full-year FY2025 number at 13.4%, up 1974.0% from a year prior.
  • EBITDA Margin was 7.51% for Q4 2025 at Repligen, up from 6.63% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 37.26% in Q4 2022 to a low of 30.9% in Q4 2024.
  • A 5-year average of 10.04% and a median of 9.84% in 2022 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: crashed -4380bps in 2023, then surged 3841bps in 2025.
  • Repligen's EBITDA Margin stood at 11.87% in 2021, then skyrocketed by 214bps to 37.26% in 2022, then crashed by -118bps to 6.54% in 2023, then crashed by -373bps to 30.9% in 2024, then surged by 124bps to 7.51% in 2025.
  • Per Business Quant, the three most recent readings for RGEN's EBITDA Margin are 7.51% (Q4 2025), 6.63% (Q3 2025), and 33.44% (Q2 2025).